Concepedia
Statistics
Publications
27
Citations
1.3K
H-Index
19
Active since
1993
Affiliations
Astellas Pharma (Japan)(Current)
Kyoto University
Jichi Medical University
Akita University
Sadao Kuromitsu is an author at Astellas Pharma (Japan) specializing in pharmacology, medicine, and oncology.
Publications per year
1993–2020
Gilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia
Masamichi Mori, Naoki Kaneko, Yoko Ueno et al. · Investigational New Drugs · 2017 · 254 citations · Full text
Medicine, Oncology, Pharmacology +16
Upregulation of TRPC1 in the development of cardiac hypertrophy
Takayoshi Ohba, Hiroyuki Watanabe, Manabu Murakami et al. · Journal of Molecular and Cellular Cardiology · 2006 · 197 citations
Life Sciences, Molecular Biology, Physiology +10
Soluble human high-affinity receptor for IgE abrogates the IgE-mediated allergic reaction
Chisel Ra, Sadao Kuromitsu, Tomohiro Hirose et al. · International Immunology · 1993 · 70 citations
Life Sciences, Immunology, Pharmacology +17
A covalent small molecule inhibitor of glutamate-oxaloacetate transaminase 1 impairs pancreatic cancer growth
Tomohiro Yoshida, Shingo Yamasaki, Osamu Kaneko et al. · Biochemical and Biophysical Research Communications · 2019 · 63 citations · Full text
Medicine, Oncology, Pharmacology +14
Synthesis and evaluation of 2-{[2-(4-hydroxyphenyl)-ethyl]amino}pyrimidine-5-carboxamide derivatives as novel STAT6 inhibitors
S. Nagashima, Masaki Yokota, Eiichi Nakai et al. · Bioorganic & Medicinal Chemistry · 2006 · 61 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +11
1–5 of 27